FORWARD FEATURES CALENDAR

Intelligence

Computer screen

FactRight launches alternative investment product and sponsor due diligence report centre

FactRight has launched a secure online report centre to better serve the alternative investment due diligence community. The password-protected site provides registered broker dealers and registered investment advisors with on-demand access to FactRight’s most popular offering and operational-level sponsor reports. The online system is configured for compatibility with both desktop

Water Street appoints Katie Ossman as vice president

Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry, has appointed Katie Ossman as vice president. Ossman (pictured) augments Water Street’s team of senior investment professionals and former executives of healthcare corporations including Baxter International, CVS Caremark Corporation, Johnson & Johnson and McKesson Corporation.   Ossman will

Monroe Capital hires Bradley Nii as Southern California group head

Monroe Capital has appointed Bradley Nii as managing director in its Los Angeles office. Nii will serve as the firm’s group head for the Southern California region.   Warren Woo, also located in Los Angeles, will continue in his current role as a partner of Monroe Capital Partners Fund, an

KKR to acquire Brickman Group for USD1.6bn

KKR is to acquire The Brickman Group for USD1.6bn from Leonard Green & Partners and other shareholders. Founded in 1939, Brickman is a provider of landscape maintenance and snow removal services in the US. With nearly 10,000 employees nationwide, Brickman serves a diversified base of over 10,000 clients.   Andrew

Canadian dollars

Manulife Financial to expand third party private asset management business

Manulife Financial is expanding its global third party private asset management business. The new business unit will be called Manulife Asset Management Private Markets.   The business unit will bring together specialised private asset teams that currently manage funds for third party investors, as well as provide investors with access

Jonathan Sablone, founder and chairperson, Nixon Peabody’s Private Funds Dispute Group

Zombie funds: is it time for managers to finally give up the ghost?

Zombie funds continue to plague the hedge fund world and are gradually extending their reach into the private equity market notes Jonathan Sablone (pictured), founder and chairperson, Nixon Peabody’s Private Funds Dispute Group.  As Reuters alluded to recently, data provided by Preqin suggests that private equity firms have up to

Graphite makes 2.3x on caravan park sale

UK mid-market private equity specialist Graphite Capital has sold Park Holidays UK, Britain's fourth largest operator of static caravan parks, to Caledonia Investments, a UK investment trust company, for GBP172m. The sale brings the total value of disposals made by Graphite since October 2012 to over GBP1bn.  Graphite has sold

Segulah IV’s portfolio company CCS Healthcare acquires Propyless

CCS Healthcare has entered into an agreement with Merck Sharp & Dohme (Sweden) to acquire the pharmaceutical skin care product and trademark Propyless. Propyless is a lotion, based on active substance propylene glycol, used for dry skin, atopic dermatitis and psoriasis. Introduced in the late 1980s it is a well-known

The Honest Company raises USD25m in financing round led by IVP

The Honest Company has secured USD25m in a financing round led by Institutional Venture Partners (IVP) and joined by ICONIQ Capital, with participation from existing investors Lightspeed Venture Partners and General Catalyst Partners. The new round of funding adds to USD27m raised previously and will accelerate growth initiatives including international

Grifols to acquire a Novartis diagnostics business unit for USD1.67bn

Grifols is expanding its portfolio by acquiring Novartis' diagnostic products for transfusion medicine and immunology in a deal worth USD1.675bn. The deal, which will be structured through Grifols' diagnostic division and a newly created 100 per cent Grifols-owned subsidiary, includes Novartis’ NAT technology (Nucleic Acid Amplification Techniques), instrumentation and equipment

Events

12 November, 2026 – 5:00 pm

Directory Listings